Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2003
Volume 27
Issue 7

Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.

Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Related Content